Document Detail


Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial.
MedLine Citation:
PMID:  22829102     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To compare the efficacy of letrozole with clomiphene citrate (CC) in Egyptian women with unexplained infertility. STUDY DESIGN: This randomized controlled trial was conducted at Ain Shams University Hospital and Dar Al Hekma hospital between February 2010 and May 2011. PATIENTS AND METHODS: Two hundreds and seventy women with unexplained infertility were randomized into two groups using computer-generated randomization plan, and were given letrozole 2.5 mg/day from cycle day 3 to 7 (Letrozole group, n = 136) or CC 100 mg/day from cycle day 3 to 7 (CC group, n = 134). On day 9, the participants underwent a transvaginal sonography (TVS) every other day to monitor their ovulation and measure both endometrial thickness and Doppler flow indices of uterine and subendometrial vessels. Single injection of 10,000 IU of human chorionic gonadotropin (hCG) was given when the mean diameter of at least one ovarian follicle was ≥18 mm, quantitative βhCG was done 2 weeks after hCG injection to diagnose chemical pregnancy. Clinical pregnancy was confirmed by observing a gestational sac with fetal echoes and pulsation 4 weeks after positive pregnancy test by TVS. RESULTS: Both groups were comparable with regard to the day of hCG administration (letrozole 13.4 ± 5 vs CC 12.1 ± 4.9, respectively, p = 0.06). The mean number of mature follicles was significantly higher in CC group (2 ± 0.9 vs 1 ± 0.0, P = 0.02). Serum estradiol was significantly greater in CC group (817 ± 299 vs 364 ± 149 pg/ml, P < 0.001). The clinical pregnancy rate was significantly higher in letrozole group (23.07 vs 10.68 %, P < 0.001). There was statistically significant increase in endometrial receptivity in letrozole group as assessed by endometrial thickness and Doppler flow indices of uterine and subendometrial vessels. No serious side effects were reported in either group. CONCLUSION: Letrozole has beneficial effect on endometrium, an action that may improve the implantation and pregnancy rates in women with unexplained infertility.
Authors:
Moustafa I Ibrahim; Rowaa A Moustafa; Ahmed A Abdel-Azeem
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-26
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  -     ISSN:  1432-0711     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt, mi_monem@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Women with one ovary in assisted reproduction technologies: a review of the literature.
Next Document:  Management of peristomal tissue necrosis following prepubic urethrostomy in a cat.